Research programme: bile salt derivativesAlternative Names: Bile salt derivatives research programme
Latest Information Update: 26 Apr 2002
At a glance
- Originator Nonindustrial sources
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 17 Jul 2000 Preclinical development for HIV infections prevention in United Kingdom (Topical)